NCT01462448

Brief Summary

The purpose of this study is to determine if there is a genetic component to phantom limb pain. DNA will be analyzed for single nucleotide polymorphisms (SNPs) between the control and phantom limb pain group. Total RNA will also be isolated and profiled to asses the degree to which our gene(s) of interest are expressed in the presence or absence of phantom limb pain. Some proteins, such as inflammatory antibodies or the neurotrophin brain-derived neurotrophic factor (BDNF), will also be assessed for their association(s) with phantom limb pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
726

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 31, 2011

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2012

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
9.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2023

Completed
Last Updated

August 12, 2025

Status Verified

August 1, 2025

Enrollment Period

2.1 years

First QC Date

October 24, 2011

Last Update Submit

August 7, 2025

Conditions

Keywords

Phantom LimbGenetic VariationDNA Sequence AnalysisAmputation, TraumaticSingle Nucleotide PolymorphismVisual Analog Pain ScaleBrain-Derived Neurotrophic FactorInflammatory AntibodyPeripheral Nerve Damage

Outcome Measures

Primary Outcomes (1)

  • Identification of Unique Single Nucleotides Polymorphisms (SNPs) associated with Phantom Limb Pain (PLP)

    The primary outcome measure for this study is the identification of unique SNPs that may correlate with PLP. Patients will undergo a one-time blood draw and fill out a survey characterizing their phantom limb pain. The PLP characteristics along with DNA analysis using Affymetrix SNP chip technology will be used to match genotype with phenotype.

    5 years

Secondary Outcomes (3)

  • Correlation between Phantom Limb Pain (PLP) and Blood Levels of Antibodies Associated with Peripheral Nerve Damage

    5 years

  • Correlation between Phantom Limb Pain (PLP) and Serum Levels of Brain-derived Neurotrophic Factor (BDNF)

    5 years

  • Correlation between Phantom Limb Pain (PLP) and Unique Transcribed RNA

    5 years

Study Arms (2)

Phantom Limb Pain

Subjects will have lower or upper extremity amputation(s) that have resulted in the presence of phantom limb pain.

Procedure: Blood Draw

No Phantom Limb Pain

Subjects in the group will have a lower or upper extremity amputation(s) without the presence of phantom limb sensation.

Procedure: Blood Draw

Interventions

Blood DrawPROCEDURE

Single blood draw of 30 ml

Also known as: Venipuncture
No Phantom Limb PainPhantom Limb Pain

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects to be recruited at WRNMMC will be military health care beneficiaries age 18 and older who have sustained one or more amputations.

Chronic PLP Group: * At least 18 years of age. * Written informed consent and written authorization for use or release of health and research study information * Single or multiple upper and/or lower limb amputation * At least three months post-amputation * Ability to follow study instructions and likely to complete required visit(s) * Experienced PLP for at least one month and at least 3 times per week * Phantom limb pain differentiated from residual limb pain by physical exam. * Subjects taking blood thinners or other medications that do not increase risk during a blood draw. Non-Chronic PLP Group: * At least 18 years of age. * Written informed consent and written authorization for use or release of health and research study information * Single or multiple upper and/or lower limb(s) amputation * At least three months post-amputation * Ability to follow study instructions and likely to complete required visit(s) * Experienced PLP less than 10 times total and/or for less than two weeks * Subjects taking blood thinners or other medications that do not increase risk during a blood draw.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Walter Reed National Military Medical Center (WRNMMC)

Bethesda, Maryland, 20889, United States

Location

Related Publications (6)

  • Montoya P, Larbig W, Grulke N, Flor H, Taub E, Birbaumer N. The relationship of phantom limb pain to other phantom limb phenomena in upper extremity amputees. Pain. 1997 Aug;72(1-2):87-93. doi: 10.1016/s0304-3959(97)00004-3.

    PMID: 9272791BACKGROUND
  • Kooijman CM, Dijkstra PU, Geertzen JHB, Elzinga A, van der Schans CP. Phantom pain and phantom sensations in upper limb amputees: an epidemiological study. Pain. 2000 Jul;87(1):33-41. doi: 10.1016/S0304-3959(00)00264-5.

    PMID: 10863043BACKGROUND
  • Ramachandran VS, Hirstein W. The perception of phantom limbs. The D. O. Hebb lecture. Brain. 1998 Sep;121 ( Pt 9):1603-30. doi: 10.1093/brain/121.9.1603.

    PMID: 9762952BACKGROUND
  • Sherman RA, Sherman CJ, Parker L. Chronic phantom and stump pain among American veterans: results of a survey. Pain. 1984 Jan;18(1):83-95. doi: 10.1016/0304-3959(84)90128-3.

    PMID: 6709380BACKGROUND
  • Katz J, Melzack R. Pain 'memories' in phantom limbs: review and clinical observations. Pain. 1990 Dec;43(3):319-336. doi: 10.1016/0304-3959(90)90029-D.

    PMID: 2293143BACKGROUND
  • Jensen TS, Krebs B, Nielsen J, Rasmussen P. Phantom limb, phantom pain and stump pain in amputees during the first 6 months following limb amputation. Pain. 1983 Nov;17(3):243-256. doi: 10.1016/0304-3959(83)90097-0.

    PMID: 6657285BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, serum

MeSH Terms

Conditions

Phantom LimbAmputation, TraumaticNeuritis

Interventions

Blood Specimen CollectionPhlebotomy

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPain, PostoperativePostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsPainWounds and InjuriesPeripheral Nervous System DiseasesNeuromuscular Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesTherapeutics

Study Officials

  • Paul F. Pasquina, MD, MC

    Walter Reed National Military Medical Center (WRNMMC)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2011

First Posted

October 31, 2011

Study Start

March 1, 2012

Primary Completion

April 1, 2014

Study Completion

August 6, 2023

Last Updated

August 12, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations